_Movinavir_400mg_01.jpg)
_Movinavir_400mg_02.jpg)
_Thuoc-Movinavir.jpg)
Each hard capsule contains:
Active ingredient:
| Molnupiravir | 400 mg |
Excipients: Pregelatinized starch, Crospovidone, Colloidal silicon dioxide, Sodium stearyl fumarate, Sodium lauryl sulfate; Pearl pink, size 0 hard capsule, printed with “BOSTON” on the body (Gelatin, purified water, tartrazine, patent blue V, ponceau 4R, mica based titanium dioxide).
Intended Use
Molnupiravir is indicated for treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness.
Dosage
Adults
- The recommended dose of Molnupiravir is 800 mg (two capsules MOVINAVIR 400) taken orally every 12 hours for 5 days.
- The safety and efficacy of molnupiravir when administered for periods longer than 5 days have not been established (see Pharmacodynamic properties).
- Molnupiravir should be administered as soon as possible after a diagnosis of COVID-19 has been made and within 5 days of symptom onset (see Pharmacodynamic properties).
Missed dose
If the patient misses a dose of Molnupiravir within 10 hours of the time it is usually taken, the patient should take as soon as possible and resume the normal dosing schedule. If a patient misses a dose by more than 10 hours, the patient should not take the missed dose and instead take the next dose at the regularly scheduled time. The patient should not double the dose to make up for a missed dose.
Special populations
- Elderly: No dose adjustment of Molnupiravir is required based on age (see Pharmacokinetic properties).
- Renal impairment: No dose adjustment is required for patients with renal impairment (see Pharmacokinetic properties).
- Hepatic impairment: No dose adjustment is required for patients with hepatic impairment (see Pharmacokinetic properties).
- Paediatric population: The safety and efficacy of Molnupiravir in patients below 18 years of age have not been established. No data are available (see Pharmacodynamic properties).
Method of administration
Contraindication
Storage
In a dry place, below 30°C, protect from light.
Shelf-life
36 months from the manufacturing date. Do not use after the expiry date.
KEEP OUT OF REACH OF CHILDREN.
READ CAREFULLY THE PACKAGE INSERT BEFORE USING.
For further information, do not hesitate to ask your physicians.
Box of 2 blister x 10 hard capsules.
Factory: No. 43, 8th Street, VSIP, Thuan An City, Binh Duong Province.
Phone: (0274) 3769 606
Office:
- At Lisbon Capital (Portugal): Campo Grande nº 28, 3.º C, - lisbon, district of Lisbon, municipality of Lisbon, parish of Alvalade.
Phone: 1900 1910
- At Ha Noi City: No.38 Duc Giang Street, Duc Giang Ward, Long Bien District, Ha Noi Capital.
Phone: (024) 7305 0606
- At Da Nang City: No.01, Ham Trung 4 Street, Hoa Hiep Nam Ward, Lien Chieu District, Da Nang City.
Phone: (023) 6730 3737
- At Nha Trang City: No.29, Thai Thong Street, Vinh Thai Commune, Nha Trang City, Khanh Hoa Province.
Phone: (025) 8389 0260
- At Ho Chi Minh City: No.41, Tran Hung Dao Street, Ward 6, District 5, Ho Chi Minh City.
Contact: (028) 3838 0606
- At Can Tho City: No.S2-3-4-5, 10th Street, Lot 11C RIVERINE Cantho City, Phu Thu Ward, Cai Rang District, Can Tho City.
Phone: (029) 2730 5959
Business Registration Certificate: No. 3700843113 issued by Binh Duong Province Department of Planning and Investment on January 11, 2007
Representative: Mr. Luong Dang Khoa.
0
Check your order
